The insulin-like growth factor-I receptor inhibitor figitumumab (CP-751,871) in combination with docetaxel in patients with advanced solid tumours: results of a phase Ib dose-escalation, open-label study

✍ Scribed by Molife, L R; Fong, P C; Paccagnella, L; Reid, A H M; Shaw, H M; Vidal, L; Arkenau, H-T; Karavasilis, V; Yap, T A; Olmos, D

• Book ID: 110000557
• Publisher: Nature Publishing Group
• Year: 2010
• Tongue: English
• Weight: 469 KB
• Volume: 103
• Category: Article
• ISSN: 0007-0920
• DOI: 10.1038/sj.bjc.6605767